Jiangsu Hengrui Medicine (600276.SS) Revenue Growth
Price: $48
Market Cap: $304.77B
Avg Volume: 47.43M
Market Cap: $304.77B
Avg Volume: 47.43M
Country: CN
Industry: Drug Manufacturers - General
Sector: Healthcare
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Jiangsu Hengrui Medicine 's Revenue Growth?
- Jiangsu Hengrui Medicine 's annual revenue growth as of FY 2024 is 22.63%.
- Jiangsu Hengrui Medicine 's quarterly revenue growth as of Q4 2024 is 18.32%.
What is Revenue Growth?
Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.
Related Metrics
Other important metrics to assess Jiangsu Hengrui Medicine 's financial performance include:
- Revenue - the total revenue generated by a company:
- Annual: $27.98B
- Quarterly: $7.80B
- Cost of Revenue - the total cost of producing the goods or services sold by a company:
- Annual: $3.85B
- Quarterly: $1.01B
- Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
- Annual Growth: 9.16%
- Quarterly Growth: 5.74%
- Gross Profit - the difference between revenue and the cost of revenue:
- Annual: $24.14B
- Quarterly: $6.78B
- Gross Profit Growth - the rate at which a company's gross profit is growing:
- Annual Growth: 25.09%
- Quarterly Growth: 20.46%
These metrics provide insights into Jiangsu Hengrui Medicine 's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Revenue Growth
22.63%
Quarterly Revenue Growth
18.32%
Historical Annual Revenue Growth
Historical Quarterly Revenue Growth
Historical Annual Revenue
Historical Quarterly Revenue
Historical Annual Cost of Revenue
Historical Quarterly Cost of Revenue
Historical Annual Gross Profit
Historical Quarterly Gross Profit
Jiangsu Hengrui Medicine Historical Revenue Growth Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Revenue | Revenue Growth | Cost of Revenue | Cost of Revenue Growth | Gross Profit | Gross Profit Growth |
|---|---|---|---|---|---|---|
| 2024 | $27.98B | 22.63% | $3.85B | 9.16% | $24.14B | 25.09% |
| 2023 | $22.82B | 7.26% | $3.53B | 1.11% | $19.29B | 8.47% |
| 2022 | $21.28B | -17.87% | $3.49B | -6.82% | $17.79B | -19.74% |
| 2021 | $25.91B | -6.59% | $3.74B | 11.74% | $22.16B | -9.11% |
| 2020 | $27.73B | 19.09% | $3.35B | 14.96% | $24.39B | 19.68% |
| 2019 | $23.29B | 33.70% | $2.91B | 24.77% | $20.38B | 35.09% |
| 2018 | $17.42B | 25.89% | $2.33B | 26.20% | $15.08B | 25.84% |
| 2017 | $13.84B | 24.72% | $1.85B | 28.94% | $11.99B | 24.09% |
| 2016 | $11.09B | 19.08% | $1.43B | 4.59% | $9.66B | 21.59% |
| 2015 | $9.32B | 25.01% | $1.37B | 4.45% | $7.94B | 29.41% |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.